Unknown Lungs & Breathing NIHR-supported project Brain & Nervous System
A Phase 2/3, Multicenter, Double-Blind, Randomized Study to Determine the Efficacy and Safety of DNL310 vs Idursulfase in Pediatric Participants With Neuronopathic or Non-Neuronopathic Mucopolysaccharidosis Type II
About this grant
This summary is based on the grant title only — the full abstract was not available.
No substantive source abstract was published for this research project funded by NIHR.
Researchers
Uma Ramaswami (Principal Investigator)
Related Research
Grants with similar aims, by meaning.
Phase 2/3, Multi-centre, Double-Blind, Randomised Study to Determine the Efficacy and Safety of DNL310 vs Idursulfase in Pediatric Participants with Neuronopathic or Non-Neuronopathic Mucopolysaccharidosis Type II
A Phase 1/2, Multicenter, Open-Label Study to Determine The Safety, Pharmacokinetics, and Pharmacodynamics of DNL310 in Pediatric Participants with Hunter Syndrome
A Phase 1/2, Multicenter, Open-Label Study to Determine The Safety, Pharmacokinetics, and Pharmacodynamics of DNL310 in Pediatric Subjects with Hunter Syndrome
DNLI-E-0002: A Phase 1/2, Multicenter, Open-Label Study to Determine The Safety, Pharmacokinetics, and Pharmacodynamics of DNL310 in Pediatric Subjects with Hunter Syndrome
FIH Study of DNL310 in paediatric patients with Hunter Syndrome
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know